Ironwood Financial Statements From 2010 to 2026

Ironwood Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 140.8 M 184.1 M 144.2 M Slightly volatile Total Assets 493.2 M 403.5 M 491.9 M Slightly volatile Short and Long Term Debt Total 723.9 M 689.4 M 378.5 M Slightly volatile Other Current Liabilities 35.9 M 35.6 M 34.8 M Slightly volatile Total Current Liabilities 81.9 M 44.7 M 76.9 M Pretty Stable Other Liabilities 8.3 M 8.8 M 41.6 M Slightly volatile Property Plant And Equipment Net 19.2 M 14 M 22.6 M Slightly volatile Current Deferred Revenue 1.7 M 1.8 M 9.6 M Pretty Stable Accounts Payable 1.8 M 1.9 M 7.8 M Slightly volatile Cash 200.7 M 101.8 M 197.1 M Slightly volatile Non Current Assets Total 145.4 M 193.8 M 153.6 M Slightly volatile Non Currrent Assets Other 6.5 M 6.8 M 47.7 M Very volatile Other Assets 1.09 1.15 73.3 M Pretty Stable Long Term Debt 705.2 M 671.6 M 344.3 M Slightly volatile Cash And Short Term Investments 96.8 M 101.8 M 247.4 M Very volatile Net Receivables 63.2 M 94.2 M 69.2 M Slightly volatile Common Stock Total Equity 125.3 K 177.1 K 136.4 K Slightly volatile Liabilities And Stockholders Equity 493.2 M 403.5 M 491.9 M Slightly volatile Non Current Liabilities Total 387.5 M 705.4 M 389.4 M Slightly volatile Other Current Assets 9.4 M 13.7 M 8.9 M Slightly volatile Other Stockholder Equity 1.1 B 1.6 B 1.2 B Slightly volatile Total Liabilities 469.4 M 750.1 M 466.3 M Slightly volatile Property Plant And Equipment Gross 20 M 21.5 M 24.1 M Pretty Stable Total Current Assets 347.8 M 209.7 M 338.2 M Slightly volatile Short Term Debt 3.5 M 3.7 M 26.9 M Slightly volatile Common Stock 130.7 K 184 K 137.6 K Slightly volatile Property Plant Equipment 5.4 M 5.7 M 17.2 M Slightly volatile Long Term Debt Total 311.5 M 455.7 M 291.7 M Slightly volatile Capital Surpluse 1.3 B 1.6 B 1.2 B Slightly volatile Capital Lease Obligations 10.4 M 17.8 M 9.5 M Slightly volatile Deferred Long Term Liabilities 13.2 M 13.9 M 34.3 M Slightly volatile Non Current Liabilities Other 12.3 M 15.4 M 13.2 M Pretty Stable Short and Long Term Debt 184.4 M 229.5 M 133.2 M Slightly volatile Long Term Investments 12.5 M 13.1 M 58.5 M Slightly volatile Net Invested Capital 400.9 M 325.1 M 381.4 M Slightly volatile Capital Stock 173.6 K 184 K 158.5 K Slightly volatile
Ironwood Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1.7 M 1.8 M 6.8 M Slightly volatile Interest Expense 20.1 M 38 M 23.8 M Slightly volatile Total Revenue 227.9 M 404.1 M 262.1 M Slightly volatile Other Operating Expenses 302.6 M 297 M 321.6 M Slightly volatile Research Development 106.2 M 128.1 M 105.2 M Pretty Stable Cost Of Revenue 6.5 M 6.8 M 26.5 M Pretty Stable Total Operating Expenses 284.5 M 288.3 M 301.6 M Slightly volatile Gross Profit 221.3 M 395.4 M 243.3 M Slightly volatile Selling General Administrative 140 M 165.9 M 136.2 M Slightly volatile Non Recurring 16.8 M 17.7 M 23.7 M Very volatile Interest Income 7.1 M 4 M 17.8 M Slightly volatile Reconciled Depreciation 1.7 M 1.8 M 8.8 M Slightly volatile
Ironwood Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation 1.7 M 1.8 M 6.9 M Slightly volatile Capital Expenditures 121.4 K 127.8 K 10 M Pretty Stable End Period Cash Flow 193.6 M 101.8 M 196.6 M Slightly volatile Stock Based Compensation 24.3 M 34.3 M 26 M Slightly volatile Begin Period Cash Flow 199.3 M 106 M 195 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.19 2.31 11.7055 Slightly volatile Days Sales Outstanding 139 97.81 137 Slightly volatile Stock Based Compensation To Revenue 0.19 0.0977 0.1676 Slightly volatile Capex To Depreciation 0.0771 0.0812 1.0897 Slightly volatile EV To Sales 3.78 3.98 11.0629 Slightly volatile Inventory Turnover 0.97 1.02 27.1359 Very volatile Days Of Inventory On Hand 672 370 699 Slightly volatile Payables Turnover 3.04 3.2 7.3655 Pretty Stable Sales General And Administrative To Revenue 1.38 0.8 1.0715 Pretty Stable Research And Ddevelopement To Revenue 0.35 0.36 1.3813 Slightly volatile Capex To Revenue 4.0E-4 5.0E-4 0.1221 Slightly volatile Cash Per Share 0.61 0.64 2.434 Slightly volatile Days Payables Outstanding 112 118 17.1 K Pretty Stable Intangibles To Total Assets 0.0089 0.0094 0.1161 Slightly volatile Current Ratio 4.92 4.23 6.5136 Pretty Stable Receivables Turnover 4.69 4.94 15.2241 Slightly volatile Capex Per Share 0.001 0.001 0.0959 Slightly volatile Revenue Per Share 1.53 1.99 1.7334 Slightly volatile Interest Debt Per Share 3.76 3.58 2.5438 Slightly volatile Debt To Assets 1.61 1.54 0.7829 Slightly volatile Graham Number 7.82 9.35 5.3858 Slightly volatile Operating Cycle 92.92 97.81 385 Slightly volatile Days Of Payables Outstanding 112 118 17.1 K Pretty Stable Ebt Per Ebit 1.13 0.81 1.0327 Slightly volatile Quick Ratio 5.05 4.23 6.4724 Pretty Stable Net Income Per E B T 0.0147 0.0155 0.607 Very volatile Cash Ratio 3.06 2.05 4.074 Pretty Stable Days Of Inventory Outstanding 672 370 699 Slightly volatile Days Of Sales Outstanding 139 97.81 137 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.49 1.15 1.2779 Very volatile Fixed Asset Turnover 21.39 20.37 13.2912 Slightly volatile Debt Ratio 1.61 1.54 0.7829 Slightly volatile Price Sales Ratio 2.19 2.31 11.7055 Slightly volatile Asset Turnover 0.95 0.9 0.5772 Slightly volatile Gross Profit Margin 0.72 0.88 0.896 Very volatile
Ironwood Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.1 B 2 B 1.9 B Slightly volatile Enterprise Value 2.4 B 2.2 B 2.1 B Slightly volatile

Ironwood Fundamental Market Drivers

Ironwood Upcoming Events

About Ironwood Pharmaceuticals Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:

How To Invest In Ironwood Details

Is Ironwood Stock a good investment? Details

What is Ironwood Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details